Financials
- Market Capitalization 981.23 M
- Employee 68
- Founded 2019
- CEO -
- Website www.altoneuroscience.com
- Headquarter Delaware, United States
- FIGI BBG00WYFS6R5
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-9.25
ratio cours/chiffre d'affaires
-4 977.22
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2487 | LXRX Lexicon Pharmaceuticals, Inc. - Common Stock | 2.19 USD | -0.45% | -3.52% | +12.31% | +68.46% | 972.79 M USD | ||
| 2490 | AVTX Avalo Therapeutics, Inc. - Common Stock | 18.86 USD | +1.67% | -5.04% | +30.88% | +284.90% | 991.39 M USD | ||
| 2510 | SLDB Solid Biosciences Inc. - Common Stock | 9.42 USD | -2.08% | -15.36% | +32.49% | +65.26% | 927.40 M USD | ||
| 2516 | PHAR Pharming Group N.V. - ADS, each representing 10 | 13.36 USD | +0.38% | -7.54% | +6.37% | +30.34% | 937.45 M USD |